AzTrials
AzTrials

Psychiatric DisorderSTERACOVIDNCT04760795

Stress, Personality, Attachment and Coping During the Covid Crisis.

An observational study of Psychiatric Disorder and Aging, run by Centre Hospitalier Universitaire de Saint Etienne at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Because of containment due to Covid-19, the French High Authority for Health (HAS) recommended reinforced monitoring of patients taken in care in the psychiatric ward, with special attention for people over the age of 65. Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Psychiatric Disorder, Aging
What is being tested?
PTSD Check List (PCL) scale, Brief COPE scale and GAD-7 (Generalized Anxiety Disorder) scale (during containment)
How many people
117 participants
Where
2 sitesFrance
Study dates
15 Nov 2020to 19 Oct 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Study population: Patients aged of 65 years old et taken in care in the psychiatric ward will be included.

Who may be able to join

  • Patients followed by teleconsultation during containment due to COVID 19
  • Patient affiliated or entitled to a social security scheme
  • Patient who received informed information about the study and who co-signed, with the investigator, a consent to participate in the study (for the part excluding routine care).

Who cannot join

  • Major neurocognitive disorder

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • CH Le Vinatier

    Bron

  • Chu Saint-Etienne

    Saint-Etienne

Other trials in France

About this study

Because of containment due to Covid-19, the French High Authority for Health (HAS) recommended reinforced monitoring of patients taken in care in the psychiatric ward, with special attention for people over the age of 65. To meet this recommendation, the geriatrics department of the hospital of Charity of Saint-Etienne hospital and the Vinatier hospital in Lyon organized follow-up of these patients by telephone throughout the containment period, thus allowing continuity of care. This pandemic situation and these measures are unprecedented; it is difficult to anticipate the psychological impact on patients.

Read the detailed description

The main objective of this study is to evaluate if the type of coping strategies usually employed has an effect on the outbreak of a post-traumatic stress after containment. In addition, a second part of the study will propose to assess the factors influencing the experience of containment such as personality, attachment style or coping strategies.

Being tested
PTSD Check List (PCL) scale, Brief COPE scale, GAD-7 (Generalized Anxiety Disorder) scale (during containment), Analog scale, GAD-7 (Generalized Anxiety Disorder) scale (post containment)
Keywords
COVID-19, teleconsultation, Stress, containment, post-traumatic stress
Medical subject headings
Mental Disorders, COVID-19

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PTSD Check List (PCL) scaleOther

    PTSD Check List (PCL) scale will be realized to evaluated post-traumatic stress disorder.

  • Brief COPE scaleOther

    Brief COPE scale dispositional version will be realized to evaluated usual coping strategies. It was assessed during the teleconsultations and post containment.

  • GAD-7 (Generalized Anxiety Disorder) scale (during containment)Other

    GAD 7 (Generalized Anxiety Disorder) scale will be realized to evaluated anxiety during containment. It was assessed during the teleconsultations.

  • Analog scaleOther

    Analog scale will be realized to evaluated anxiety during containment. It was assessed during the teleconsultations.

  • GAD-7 (Generalized Anxiety Disorder) scale (post containment)Other

    GAD-7 (Generalized Anxiety Disorder) scale will be realized to evaluated anxiety during post containment.

  • Big Five Inventory (BFI) scaleOther

    Big Five Inventory (BFI) will be realized to evaluated personality.

  • Relationship Scales Questionnaire (RSQ)Other

    Relationship Scales Questionnaire (RSQ) will be realized to evaluated attachment style.

Study groups in NCT04760795
Study groupRoleWhat they receive
coping strategy based on problem59 geriatric patients will be included on the group: coping strategy based on problem
Receives: Other: PTSD Check List (PCL) scale; Other: Brief COPE scale; Other: GAD-7 (Generalized Anxiety Disorder) scale (during containment); Other: Analog scale; Other: GAD-7 (Generalized Anxiety Disorder) scale (post containment); Other: Big Five Inventory (BFI) scale; Other: Relationship Scales Questionnaire (RSQ)
coping strategy based on emotion59 geriatric patients will be included on the group: coping strategy based on emotion
Receives: Other: PTSD Check List (PCL) scale; Other: Brief COPE scale; Other: GAD-7 (Generalized Anxiety Disorder) scale (during containment); Other: Analog scale; Other: GAD-7 (Generalized Anxiety Disorder) scale (post containment); Other: Big Five Inventory (BFI) scale; Other: Relationship Scales Questionnaire (RSQ)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Analysis post traumatic stress disorder measured by PTSD Check List (PCL) results

    The PTSD Check List (PCL) is a self-questionnaire to assess the post traumatic stress disorder and contains 17 items with minimum score 17 (no post traumatic stress disorder) and maximum score at 85 (post traumatic stress disorder important).

    Measured: Year: 1

Secondary outcomes (9)
  1. Analysis usual coping strategies measured by brief COPE (dispositional version) results

    Brief COPE (dispositional version) is a questionnaire to assess the usual coping strategies and contains 28 items with minimum score 28 (not at all) and maximum score at 112 (a lot).

    Measured: Year: 1

  2. Analysis of situation of patients

    It is composite of analysis of socio-demographic data, conditions of confinement, diagnostic elements. It was collected in the medical record.

    Measured: Year: 1

  3. Analysis usual coping strategies during containment measured by brief COPE (dispositional version) results

    Brief COPE (dispositional version) is a questionnaire to assess the usual coping strategies during containment and contains 28 items with minimum score 28 (not at all) and maximum score at 112 (a lot).

    Measured: Year: 1

  4. Analysis anxiety during containment measured by GAD-7 (Generalized Anxiety Disorder) results

    GAD-7 (Generalized Anxiety Disorder) is a questionnaire to assess the anxiety during containment and contains 7 items with minimum score 0 (not anxiety) and maximum score at 21 (anxiety).

    Measured: Year: 1

  5. Analysis anxiety related to the containment context measured by analogue scale

    Analogue scale contains minimum score 0 (absence of stress) and maximum score at 10 (stress maximal).

    Measured: Year: 1

  6. Analysis anxiety post containment measured by GAD-7 (Generalized Anxiety Disorder) results

    GAD-7 (Generalized Anxiety Disorder) is a questionnaire to assess the anxiety post containment and contains 7 items with minimum score 0 (not anxiety) and maximum score at 21 (anxiety).

    Measured: Year: 1

  7. Analysis of personalities by Big Five Inventory (BFI) scale

    Big Five Inventory (BFI) scale to assess the personalities and contains 45 items with 5 dimensions: openness, awareness, extroversion, agreeableness and neurosis.

    Measured: Year: 1

  8. Analysis attachment measured by Relationship Scales Questionnaire (RSQ) scale results

    Relationship Scales Questionnaire (RSQ) scale is a questionnaire to assess attachment style and contains 30 items to identify 2 latent dimensions: the "model of oneself" and the "model of the others".

    Measured: Year: 1

  9. presence of traumatic life events

    Analysis of presence of traumatic life events

    Measured: Year: 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Feb 2021
  2. Study start15 Nov 2020
  3. Primary completion19 Oct 2022
  4. Study completion19 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
117 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04760795
Sponsor's protocol ID
IRBN922020
Acronym
STERACOVID
Status last verified
Jul 2023
First submitted
17 Feb 2021
Last updated
28 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Pongan E, Rouch I, Herrmann M, Perrot C, Lebrun-Givois C, Spirli L, Briollet C, Martin HS, Laurent B, Bachelet R, El Haouari H, Buisson A, Edjolo A, Dorey JM. Anxiety symptoms during COVID-19 in older adults with psychiatric disorders. Front Psychiatry. 2023 Jan 16;13:1082807. doi: 10.3389/fpsyt.2022.1082807. eCollection 2022.

    PubMed 36741567
  • Edjolo A, Dorey JM, Herrmann M, Perrot C, Lebrun-Givois C, Buisson A, El Haouari H, Laurent B, Pongan E, Rouch I. Stress, Personality, Attachment, and Coping Strategies During the COVID-19 Pandemic: The STERACOVID Prospective Cohort Study Protocol. Front Psychiatry. 2022 Jun 27;13:918428. doi: 10.3389/fpsyt.2022.918428. eCollection 2022.

    PubMed 35832598

Questions about this trial

What is this clinical trial studying?

An observational study of Psychiatric Disorder and Aging, run by Centre Hospitalier Universitaire de Saint Etienne at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Analysis post traumatic stress disorder measured by PTSD Check List (PCL) results (time frame: Year: 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04760795, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in